000047198 000__ 01343cam\a22003735i\4500
000047198 001__ 47198
000047198 003__ SzGeWIPO
000047198 005__ 20240708150327.0
000047198 006__ m\\\\eo\\d\\\\\\\\
000047198 007__ cr bn |||m|||a
000047198 008__ 221111s2022\\\\nyu\\\\\o\\\\\000\0\eng\d
000047198 035__ $$a(OCoLC)1348117298
000047198 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000047198 041__ $$aeng
000047198 24500 $$aRepositioning generic drugs: empirical findings and policy implications
000047198 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2022
000047198 300__ $$a1 online resource
000047198 336__ $$atext$$2rdacontent
000047198 337__ $$acomputer$$2rdamedia
000047198 338__ $$aonline resource$$bcr$$2rdacarrier
000047198 4901_ $$aInternational Review of Intellectual Property Law & Competition Law,$$vVolume 53, Issue 9
000047198 542__ $$fhttps://1.next.westlaw.com/Copyright
000047198 588__ $$aCrossref
000047198 590__ $$aPublished online: 2022
000047198 650_0 $$aIntellectual property.
000047198 650_0 $$aHealth
000047198 650_0 $$aPatents
000047198 650_0 $$aClinical trials
000047198 7001_ $$aLiddicoat, Johnathon,$$eauthor.
000047198 7001_ $$aLiddell, Kathleen,$$eauthor.
000047198 7001_ $$aAboy, Mateo,$$eauthor.
000047198 7001_ $$aDarrow, Jonathan,$$eauthor.
000047198 7001_ $$aJordan, Matthew,$$eauthor.
000047198 7001_ $$aMinssen, Timo,$$eauthor.
000047198 7001_ $$aCrespo, Cristina,$$eauthor.
000047198 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000047198 7731_ $$wIIC
000047198 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vIIC 2022, 53(9), 1287-1322
000047198 85641 $$uhttps://www.westlaw.com/Document/IFD82C4B0615A11EDB12786654F5D4C17/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000047198 904__ $$aJournal article
000047198 980__ $$aIIC